Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
38
Frequently Asked Questions
What is Market Cap of Kala Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kala Bio Inc. market cap is $98.29M.
What is the 52-week high for Kala Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kala Bio Inc. 52 week high is $15.80 as of September 10, 2025.
What is the 52-week low for Kala Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kala Bio Inc. 52 week low is $2.92 as of September 10, 2025.
What is Kala Bio Inc. stock price today?
Kala Bio Inc. stock price today is $15.27.
What was Kala Bio Inc. stock price yesterday?
Kala Bio Inc. stock price yesterday was $14.00.
What is the PE ratio of Kala Bio Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kala Bio Inc.’s P/E ratio is -2.06.
What is the Price-to-Book ratio of Kala Bio Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kala Bio Inc. P/B ratio is -29.1667.
What is the 50-day moving average of Kala Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kala Bio Inc. 50-day moving average is $8.02.
KALA Kala Pharmaceuticals Inc